Articles

Poll

Podcasts

Slideshows

Videos

Nephrology

The HCPLive nephrology page is a resource for medical news and expert insights on kidney disease. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in nephrology, and more.

The first half of 2025 recap for nephrology spotlights renal FDA action, ERA 2025 Congress coverage, and updates in xenotransplantation.

Nephrology First Half Recap: 2025

The Q2 recap for nephrology spotlights key FDA decisions and top coverage from the 62nd European Renal Association Congress.

Q2 2025 Recap: Nephrology News and Updates

The month in review spotlights renal regulatory news and clinical trial data as well as coverage of the 62nd European Renal Association Congress.

Nephrology Month in Review: June 2025

From new data for potential IgAN treatments to the use of combination initiation therapy for type 2 diabetes and CKD, here are 5 key updates from the annual meeting.

HCPLive Five at European Renal Association (ERA) Congress 2025

A recap of 3 Kidney Compass podcast episodes recorded at ERA 2025, including summaries and preview clips. 

Kidney Compass: ERA 2025 Recap

A recap of 5 studies to know from the ERA 2025 Congress, including expert perspectives. 

ERA 2025 Recap: 5 Studies to Know

A deep dive into several noteworthy IgAN studies presented during the ERA 2025 Congress. 

Kidney Compass: Key Updates in IgA Nephropathy at ERA 2025, with Chee Kay Cheung, MBChB, PhD

Discover groundbreaking insights on the VISIONARY trial, IgA nephropathy treatment, and the future of kidney care with expert Vlado Perkovic, MBBS, PhD.

Kidney Compass: Sibeprenlimab and the VISIONARY Trial, with Vlado Perkovic, MBBS, PhD, at ERA 2025

Jonathan Barratt, MD, PhD, discusses results from an open-label trial of mezagitamab from ERA 2025. 

Mezagitamab Shows Promise for IgA Nephropathy in Phase 1b Trial, with Jonathan Barratt, MD, PhD

Prespecified analysis of 320 patients in VISIONARY were presented at ERA 2025 Congress.

ERA 2025: Sibeprenlimab Halves Proteinuria in IgAN in Phase 3 VISIONARY Trial

The HCPLive Berger disease page is a resource for medical news and expert insights on IgA nephropathy. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments in Berger disease, and more.